FR2034471A1 - - Google Patents

Info

Publication number
FR2034471A1
FR2034471A1 FR7001580A FR7001580A FR2034471A1 FR 2034471 A1 FR2034471 A1 FR 2034471A1 FR 7001580 A FR7001580 A FR 7001580A FR 7001580 A FR7001580 A FR 7001580A FR 2034471 A1 FR2034471 A1 FR 2034471A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7001580A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2034471A1 publication Critical patent/FR2034471A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR7001580A 1969-01-16 1970-01-16 Withdrawn FR2034471A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH63769 1969-01-16

Publications (1)

Publication Number Publication Date
FR2034471A1 true FR2034471A1 (fr) 1970-12-11

Family

ID=4191643

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7001580A Withdrawn FR2034471A1 (fr) 1969-01-16 1970-01-16

Country Status (6)

Country Link
US (1) US3642839A (fr)
AU (1) AU1005270A (fr)
BE (1) BE744456A (fr)
DE (1) DE2001262A1 (fr)
FR (1) FR2034471A1 (fr)
NL (1) NL7000357A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone

Also Published As

Publication number Publication date
BE744456A (fr) 1970-07-15
NL7000357A (fr) 1970-07-20
DE2001262A1 (de) 1970-07-30
US3642839A (en) 1972-02-15
AU1005270A (en) 1971-07-08

Similar Documents

Publication Publication Date Title
AU465413B2 (fr)
AU429630B2 (fr)
AU450150B2 (fr)
FR2034471A1 (fr)
AU427401B2 (fr)
AU470301B1 (fr)
AU428074B2 (fr)
AU428129B2 (fr)
AU442535B2 (fr)
AU438128B2 (fr)
AU442538B2 (fr)
AU442285B2 (fr)
AU442380B2 (fr)
AU470661B1 (fr)
AU442322B2 (fr)
AU442463B2 (fr)
AU428131B2 (fr)
AU442554B2 (fr)
AU414607B2 (fr)
AU442357B2 (fr)
AU417208B2 (fr)
AU425297B2 (fr)
CH382170A4 (fr)
AU4982068A (fr)
AU448562A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse